Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05410561 · ClinicalTrials.gov registry record · NA
Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients
A NA study of Substance Use Disorders and Substance Use, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT05410561: Active NA study of Substance Use Disorders and Substance Use, sponsored by University of Michigan.
NCT05410561 is a NA study of Substance Use Disorders and Substance Use that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 300 participants, below the 497-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05410561, a NA study of Substance Use Disorders and Substance Use, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this trial is to test new programs to see if they might help people manage their health and health behaviors related to alcohol use and well-being. The program sessions focus on getting to know what's important to the participants, reviewing or setting goals, and using different skills and behaviors to better manage health. The trial will help the study team learn about ways to deliver health information in a way that is useful and interesting. This research will take place remotely (e.g., Zoom, Facetime, Phone) and participants will be randomized to the Telehealth (TeleTx) group intervention or the Enhanced Usual Care (EUC) control group. Both groups will be asked to have follow-up visits up to 12 months from the baseline visit.
Primary Outcome
Percent of patients who initiate Alcohol Use Disorder psychotherapy treatment
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Usual Care (EUC)
- BEHAVIORAL TeleTx intervention
Study Locations (2)
Michigan
- VA Ann Arbor Health Care | Veterans Affairs - Ann Arbor
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT05410561 still lists
NCT05410561 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 497-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (40% lower).
The record links to 3 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care (EUC) is the first listed.
NCT05410561 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05410561 about?
NCT05410561 is a clinical study titled "Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients". The purpose of this trial is to test new programs to see if they might help people manage their health and health behaviors related to alcohol use and well-being. The program sessions focus on getting to know what's important to the participants, reviewing or setting goals, and using different skill...
What is the current status of trial NCT05410561?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-11-01. Estimated completion is 2026-04-30.
What conditions does trial NCT05410561 study?
This clinical trial studies the following conditions: Substance Use Disorders, Substance Use, Substance Dependence.
What interventions are being tested in trial NCT05410561?
The interventions under investigation include: Enhanced Usual Care (EUC) (BEHAVIORAL), TeleTx intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05410561?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05410561 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05410561's enrollment target sits among peer trials
300 18th of 93 higher than 74 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI